Nucleic acid molecules and dual-functional peptides having antiviral activity and delivery activity, compositions and methods thereof
AssigneeThe University of Hong Kong
InventorsHanjun Zhao, Kai Wang Kelvin To, Kwok Yung Yuen
Life of this patent
Estimating the term…
Abstract
Disclosed are delivery and expression systems of multiple antiviral therapeutic molecules. The therapeutic molecules include a novel class of dual-functional peptide and defective interfering genes of a virus. Also disclosed are compositions comprising the therapeutic molecules that are useful for the treatment and prevention of viral infections. Also disclosed herein are the method of making and using a vector that expresses the therapeutic molecules. Therapeutic molecules include cellular components such as RNA, DNA, peptide, proteins or combination thereof.
Claims10
A vector comprising one or more viral genes wherein each of the viral genes comprises a deletion to form a detective interfering gene (DIG), the vector expresses one or more nucleic acid molecules that interfere with expression of one or more wild-type viral genes that do not comprise the deletion, the DIG consists of one or more defective genes, that express detective interfering RNAs without any full-length viral RNA and do not generate self-replicable reassortants, wherein
- the vector further comprises a dual-functional peptide comprising an HIV-1 Tat Peptide (TAT) and a cationic peptide comprising SEQ ID NO:
- 4 (P1);
- the DIG is a defective viral polymerase gene;
- the viral polymerase genes are PB2, PB1 and PA;
- the DIG comprises defective PB2, PB1 and PA;
- and
- the DIG comprises SEQ ID NO:
- 38 (DI-PA), SEQ ID NO:
- 39 (DI-PB1) and SEQ ID NO:
- 40 (DI-PB2).
A vector comprising one or more viral genes wherein each of the viral genes comprises a deletion to form a detective interfering gene (DIG), said vector expresses one or more nucleic acid molecules that interfere with expression of one or more wild-type viral genes that do not comprise the deletion, the DIG consists of one or more defective genes, that express detective interfering RNAs without any full-length viral RNA and do not generate self-replicable reassortants, wherein
- the vector further comprises a dual-functional peptide comprising an HIV-1 Tat Peptide (TAT) and a cationic peptide, comprising SEQ ID NO:
- 4 (P1);
- the DIG is a defective viral polymerase gene;
- the viral polymerase genes are PB2, PB1 and PA;
- the DIG comprises defective PB2, PB1 and PA;
- and
- the DIG comprises SEQ ID NO:
- 38 (DI-PA), SEQ ID NO:
- 39 (DI-PB1) and SEQ ID NO:
- 40 (DI-PB2),
- wherein the deletion is about 50-100 base pair, 100-150 base pair, 150-200 base pair, 200-250 base pair, 250-300 base pair, 300-350 base pair, 350-400 base pair, 400-450 base pair, 450-500 base pair, 500-550 base pair, 550-600 base pair, 600-650 base pair, 650-700 base pair, 700-750 base pair, 750-800 base pair, 800-850 base pair, 850-900 base pair, 900-950 base pair, 950-1000 base pair, 1000-1200 base pair, 1200-1500 base pair, 1500-1800 base pair, or 1800-2100 base pair in length.
Dependencies are inferred from the claim text.